[ Neoton and thrombolytic therapy of <font color="red">myocardial_2</font> <font color="red">infarction_2</font> <font color="red">]_2</font> . 
<br>
<br> AIM To evaluate neoton therapy effects in <font color="red">acute_2</font> <font color="red">myocardial_2</font> <font color="red">infarction_2</font> <font color="red">(_2</font> <font color="red">MI_2</font> <font color="red">)_2</font> on systolic function of the left ventricle , arrhythmia and clinical symptoms in <font color="red">patients_1</font> <font color="red">on_1</font> <font color="red">thrombolytic_1</font> <font color="red">therapy_1</font> <font color="red">(_1</font> <font color="red">TLT_1</font> <font color="red">)_1</font> <font color="red">._1</font> 
<br> MATERIAL AND METHODS <font color="red">106_2</font> <font color="red">males_2</font> <font color="red">with_2</font> <font color="red">Q_2</font> <font color="red">-_2</font> <font color="red">MI_2</font> <font color="red">entered_1</font> <font color="red">the_1</font> <font color="red">study_1</font> <font color="red">._1</font> <font color="red">47_1</font> <font color="red">received_1</font> <font color="red">treatment_1</font> <font color="red">without_1</font> <font color="red">TLT_1</font> <font color="red">and_1</font> <font color="red">neoton_1</font> <font color="red">,_1</font> <font color="red">30_1</font> <font color="red">patients_1</font> <font color="red">received_1</font> <font color="red">TLT_1</font> <font color="red">with_1</font> <font color="red">streptokinase_1</font> <font color="red">preparations_1</font> <font color="red">,_1</font> <font color="red">29_1</font> <font color="red">patients_1</font> <font color="red">were_1</font> <font color="red">given_1</font> <font color="red">streptokinase_1</font> <font color="red">preparations_1</font> <font color="red">and_1</font> <font color="red">neoton_1</font> <font color="red">._1</font> Left ventricular systolic function was measured by echocardiography on day 1 , 3 , 7 , 14 , 21 and 28 ; arrhythmia was analysed at Holter monitoring in day 1 and 2 of <font color="red">MI_1</font> <font color="red">._1</font> 
<br> RESULTS TLT failed to arrest progression of left ventricular dilation by the end of the hospital stay . Patients given neoton in acute period of <font color="red">MI_1</font> had no increase in the end systolic and diastolic volumes of the left ventricle in the course of the first months after <font color="red">MI_1</font> onset . Antiarrhythmic action of neoton manifested on <font color="red">MI_1</font> day 2 . 
<br> CONCLUSION Neoton given to <font color="red">MI_2</font> <font color="red">patients_2</font> receiving TLT prevents progression of left ventricular systolic dysfunction and establishment of predictors of unfavourable outcome .